Formula: | C16H23N5O3S |
Molecular Weight: | 365.46 |
Rotatable Bond Donors: | 7 |
clogP: | 1.05 |
Topological Polar Surface Area: | 80.56 |
Lipinski's RO5: | MW: 365.46 HBA: 8 HBD: 0 RB: 7 LogP: 1.05 |
Rule of Three: | MW: 365.46 HBA: 8 HBD: 0 RB: 7 LogP: 1.05 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS17867 | 0.74 | EOS17867 RDKit 3D 29 32 0 0 0 0 0 0 0 0999 V2000 5.4890 -1.8709 -0.1403 O 0 0 0 0 0 0 0 0 0 0 0 0 4.6018 -2.7744 -0.8413 S 0 0 0 0 0 0 0 0 0 0 0 0 4.9302 -4.1792 -0.9781 O 0 0 0 0 0 0 0 0 0 0 0 0 4.2944 -2.1677 -2.5064 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9634 -0.7086 -2.5265 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9535 0.2535 -2.3192 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6477 1.6117 -2.3951 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3516 2.0127 -2.7045 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.0588 -2.9441 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6740 -0.2984 -2.8667 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1097 -2.7066 -0.0819 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0095 -3.5073 -0.6388 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7455 -2.7837 -0.2156 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1846 -1.3378 -0.1430 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3396 -0.5243 0.6788 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3183 0.5994 0.2740 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9953 0.9913 1.4092 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9015 2.1386 1.6180 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1072 2.0288 0.8682 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.0766 1.4547 1.7362 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.4357 1.8059 1.2362 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0527 1.0122 0.2696 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.3271 1.3376 -0.1912 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.9840 2.4587 0.3124 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.3710 3.2514 1.2788 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.1002 2.9224 1.7442 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7144 0.1214 2.4324 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1187 -0.8023 1.9718 N 0 0 0 0 0 0 0 0 0 0 0 0 2.6063 -1.3981 0.3735 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 2 0 2 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 2 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 2 0 17 27 1 0 27 28 2 0 14 29 1 0 10 5 1 0 29 11 1 0 28 15 1 0 26 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |